Ultragenyx Pharmaceutical | RARE - EPS Earnings Per Share


Ultragenyx Pharmaceutical reported $-1.81 in EPS Earnings Per Share for its fiscal quarter ending in September of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2025Q4 Dec/2025 -1.17 -1.39 Feb/12 2026
FY2025Q3 Sep/2025 -1.81 -1.23 -1.40 Nov/04 2025
FY2025Q2 Jun/2025 -1.17 -1.29 -1.52 Aug/05 2025
FY2025Q1 Mar/2025 -1.57 -1.53 -2.03 May/06 2025
FY2024Q4 Dec/2024 -1.39 -1.34 -1.52 Feb/13 2025




Eps Change Date
Acadia Pharmaceuticals USD 0.42 0.26 Sep/2025
Agios Pharmaceuticals USD -1.78 0.15 Sep/2025
Alnylam Pharmaceuticals USD 2.9 2.58 Sep/2025
BioMarin Pharmaceutical USD 0.12 1.32 Sep/2025
Insmed USD -1.75 0.05 Sep/2025
Ionis Pharmaceuticals USD -0.8 1.5 Sep/2025
Kyowa Hakko Kirin JPY 31.1 11.7 Sep/2025
MacroGenics USD 0.27 0.84 Sep/2025
Moderna USD -0.51 1.62 Sep/2025
Neurocrine Biosciences USD 2.17 0.52 Sep/2025
PTC Therapeutics USD 0.2 1.03 Sep/2025
Regeneron Pharmaceuticals USD 11.44 0.39 Dec/2025
Sarepta Therapeutics USD -0.13 2.15 Sep/2025
Ultragenyx Pharmaceutical USD -1.81 0.64 Sep/2025
Vertex Pharmaceuticals USD 4.8 0.28 Sep/2025